ONESOURCE SPECL PHARMA L (ONESOURCE)

NSE: ₹1,837.90
BSE: ₹1,837.50
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 67.98 336.75 477.41 321.01 375.19 290.22 418.96 446.47
YOY Revenue Growth % - - - - 451.91% -13.82% -12.24% 39.08%
Other Income 0.58 5.02 3.91 5.26 3.04 4.62 2.09 3.79
Total Income 68.56 341.76 481.32 326.27 378.22 294.84 421.06 450.26
Total Expenses + 107.63 314.26 306.45 301.45 341.12 349.94 401.25 399.03
Cost of Materials Consumed 12.31 87.35 94.60 87.55 123.43 87.24 145.43 141.19
Employee Benefit Expense 22.78 57.19 50.94 58.15 62.53 64.06 61.65 68.39
Other Expenses 32.77 84.32 77.23 90.50 97.71 119.45 135.42 121.63
Operating Profit -39.65 22.49 170.97 19.56 34.07 -59.72 17.72 47.44
OPM % -58.3% 6.7% 35.8% 6.1% 9.1% -20.6% 4.2% 10.6%
Profit Before Tax + -40.02 -73.02 174.88 24.82 37.10 -62.19 21.48 51.23
Tax Expense 0.00 0.00 0.69 0.00 0.00 0.00 0.00 0.00
Tax % - - 0.4% 0% 0% - 0% 0%
Profit After Tax -40.02 -73.02 174.19 24.82 37.10 -62.19 21.48 51.23
EPS (Basic) -19.26 -6.69 15.28 2.17 3.24 -5.43 1.87 4.47

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025
Revenue from Operations 1,405.38 1,299.59
YOY Revenue Growth % 8.14% -
Other Income 15.01 17.68
Total Income 1,420.39 1,317.27
Total Expenses + 1,393.76 1,226.48
Cost of Materials Consumed 441.26 330.17
Employee Benefit Expense 240.45 214.80
Other Expenses 451.41 307.33
Operating Profit 11.62 73.11
OPM % 0.8% 5.6%
Profit Before Exceptional 26.63 90.80
Exceptional Items -5.42 -112.25
Profit Before Tax + 21.21 -21.46
Tax Expense 0.00 -40.77
Tax % 0% -
Profit After Tax 21.21 19.31
EPS (Basic) 1.85 1.81

Balance Sheet

Particulars Mar 2026 Mar 2025
ASSETS
Non-Current Assets + 6,819.03 6,366.58
Property, Plant & Equipment 925.86 897.35
Capital Work in Progress 313.90 60.37
Non-Current Investments 2,925.72 2,839.17
Goodwill 1,976.14 1,976.14
Other Intangible Assets 295.58 326.80
Current Assets + 1,457.03 1,023.88
Inventories 438.96 153.44
Trade Receivables 735.25 441.97
Cash and Cash Equivalents 28.06 83.20
Current Investments 5.46 8.88
LIABILITIES & EQUITY
Total Equity 5,950.22 5,920.10
Equity Share Capital 11.46 11.44
Other Equity 5,938.76 5,908.66
Non-Current Liabilities 801.91 400.88
Current Liabilities 1,523.93 1,069.48
Total Liabilities 2,325.84 1,470.36

Cash Flow Statement

Particulars Mar 2026 Mar 2025
Cash from Operating Activities 55.18 -46.59
Cash from Investing Activities -477.60 145.78
Cash from Financing Activities 361.06 1,981.97
Net Increase/Decrease in Cash -61.37 2,081.15